Meeting
2013 ASCO Annual Meeting
Impact of body mass index (BMI) on the prognosis of women with high-risk early breast cancer (BC) receiving adjuvant chemotherapy (CT).
Authors
Alessandra Gennari
E.O. Ospedali Galliera, Genoa, Italy
Alessandra Gennari , Oriana Nanni , Emanuela Scarpi , Lorenzo Cecconetto , Samanta Sarti , Dino Amadori
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - HER2/ER
Track
Breast Cancer
Sub Track
ER+
Citation
J Clin Oncol 31, 2013 (suppl; abstr 552)
DOI
10.1200/jco.2013.31.15_suppl.552
Abstract #
552
Poster Bd #
2G
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
The prognostic role of progesterone receptor in patients with rapidly proliferating, hormone receptor-positive early breast cancer.
First Author: Sara Bravaccini
Poster
2014 ASCO Annual Meeting
Comparison of the clinical treatment score with the adjuvant online score and the risk for recurrence score for estimating prognosis in early-stage high-risk breast cancer patients: A Hellenic Cooperative Oncology Group study.
First Author: Kyriaki Pliarchopoulou
Poster
2011 ASCO Annual Meeting
Benefit from CMF with or without anthracyclines in relation to biologic profiles in early breast cancer.
First Author: A. Rocca
Poster
2018 ASCO Annual Meeting
Persistence of circulating tumor cells in high risk early breast cancer patients five years after adjuvant chemotherapy and late recurrence: Results from the adjuvant SUCCESS A trial.
First Author: Wolfgang Janni